Doctors Note Logo

Published on: 7/2/2026

Removing the Stigma: Why Obesity is a Chronic Disease

Obesity is a chronic disease affecting more than 650 million adults worldwide, driven by persistent biological, genetic, and hormonal factors that require ongoing, personalized management. Classifying obesity as a disease—rather than a lifestyle failure—shifts the focus from blame to evidence-based, comprehensive care.

Key factors include genetic predisposition, hormonal regulation of appetite and metabolism, the growing role of GLP-1 receptor agonist therapies, and the measurable health impact of weight stigma. Understanding these drivers is essential to building an effective, individualized treatment plan.

Because obesity interacts with dozens of other conditions—from sleep apnea and type 2 diabetes to joint pain and mood changes—identifying your specific symptoms is a critical first step. Take a free, instant, online symptom check to better understand what's going on in your body and get clear, personalized guidance on your next steps.

Reviewed for medical accuracy: 07/02/2026

answer background

Explanation

Removing the Stigma: Why Obesity Is a Chronic Disease

Obesity affects more than 650 million adults worldwide and is often met with judgment, blame and misconceptions. Many see it as a matter of willpower or a personal failing rather than a complex medical condition. In reality, obesity meets the criteria for a chronic disease: it persists over time, involves multiple body systems, often requires long-term management and carries significant health risks. Recognizing obesity as a chronic disease is the first step toward removing stigma and ensuring people receive the comprehensive care they deserve.

What Makes Obesity a Chronic Disease?

Medical organizations including the American Medical Association (AMA), the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) classify obesity as a disease. Key factors:

  • Persistent nature
    Weight gain is often gradual and, once established, difficult to reverse or maintain off without ongoing support.
  • Biological underpinnings
    Genetics, hormonal signals and metabolic adaptations all contribute—much like in type 2 diabetes or hypertension.
  • Long-term treatment needs
    Effective management often requires a combination of lifestyle changes, medications, counseling and sometimes surgery.

The Biology Behind Obesity

At its core, obesity reflects an imbalance in energy regulation. But it's not just "calories in vs. calories out." Complex systems regulate appetite, fat storage and energy use:

  • Hormonal control
    • Leptin (signals fullness)
    • Ghrelin (triggers hunger)
    • GLP-1 (glucagon-like peptide-1) slows gastric emptying and promotes satiety
  • Set-point theory
    The body defends a certain weight range by adjusting metabolism and appetite—making long-term weight loss challenging.
  • Neural pathways
    Brain regions involved in reward and stress can drive overeating in response to emotional or environmental cues.

Genetics account for 40–70% of BMI variability. Meanwhile, modern living—easy access to calorie-dense foods, sedentary lifestyles and stress—creates an "obesogenic" environment that overwhelms our biological systems.

Chronic Disease Parallels

Obesity shares many traits with other chronic conditions:

  • It often coexists with high blood pressure, high cholesterol and type 2 diabetes.
  • Like asthma or rheumatoid arthritis, it may go through periods of remission and relapse.
  • Management is ongoing; stopping treatment usually leads to recurrence.
  • Early intervention can reduce the risk of complications later.

By viewing obesity through a chronic-disease lens, healthcare providers can focus on holistic, long-term strategies rather than short-lived diets or blame.

GLP-1 and the "Weight Loss Drug" Stigma

GLP-1 receptor agonists (for example, semaglutide and liraglutide) mimic the body's natural GLP-1 hormone. They:

  • Slow stomach emptying
  • Decrease appetite
  • Improve blood sugar control

Initially developed for type 2 diabetes, these medications earned headlines as "weight loss drugs." That label, however, has fueled stigma. Common misconceptions include:

  • "It's cheating"
  • "You didn't earn your results"
  • "Taking a pill is the easy way out"

In reality:

  • GLP-1 drugs require a prescription, ongoing monitoring and active participation in lifestyle changes.
  • Side effects (nausea, headaches) and costs can be barriers, not shortcuts.
  • Long-term safety data are still emerging, and stopping medication often leads to weight regain—underscoring obesity's chronic nature.

Comparing GLP-1 to insulin for diabetes may help shift perceptions: both are hormone-based therapies that correct underlying imbalances, not just "help" with eating less.

How Stigma Harms

Weight stigma isn't just unpleasant—it has real health impacts:

  • Mental health toll
    Shame, anxiety and depression can arise from negative comments or self-criticism.
  • Avoidance of care
    Fear of judgment may lead people to delay or skip medical appointments.
  • Unhealthy behaviors
    Dieting cycles, stress eating and physical inactivity can worsen weight and metabolic health.
  • Reduced effectiveness of interventions
    A punitive approach undermines motivation and resilience.

Creating a supportive, nonjudgmental environment is critical. Celebrating small wins and focusing on behavior changes rather than the scale can help people stay engaged in their care.

A Comprehensive, Personalized Approach

Just as with other chronic diseases, obesity management should be tailored to the individual. Key components include:

  • Medical evaluation
    Assess underlying conditions (thyroid disorders, sleep apnea, hormonal imbalances).
  • Lifestyle strategies
    • Balanced, nutrient-dense eating plans
    • Regular physical activity adapted to abilities
    • Sleep hygiene and stress management
  • Behavioral support
    • Counseling or coaching
    • Support groups or digital tools
  • Pharmacotherapy
    • GLP-1 receptor agonists and other approved medications
    • Monitoring for effectiveness and side effects
  • Surgical options
    • For those with severe obesity or related complications

This multimodal approach recognizes that no single solution works for everyone. Removing barriers—financial, logistical or psychological—is as important as the treatments themselves.

Take the First Step: Free Symptom Check

If you're concerned about your weight or overall health, understanding whether your symptoms align with obesity as a medical condition can be an important first step. Ubie's free AI-powered tool helps you assess your risk factors, learn about potential complications and determine when professional care may be needed—all in just a few minutes.

When to Speak to a Doctor

Obesity can increase the risk of serious conditions, including:

  • Heart disease
  • Stroke
  • Type 2 diabetes
  • Certain cancers

If you experience severe symptoms (chest pain, shortness of breath, unexplained weight changes) or if you're thinking about starting a new medication or weight-loss program, it's important to speak to a doctor. A healthcare professional can:

  • Evaluate your individual risk
  • Order necessary tests
  • Help you develop a safe and effective plan

Conclusion

Obesity is not a moral failing or a sign of weakness—it is a chronic, multifactorial disease. By understanding its biological roots, recognizing the role of hormones like GLP-1 and challenging the "weight loss drug" stigma, we can move toward compassionate, evidence-based care. Removing shame and blame helps people engage in long-term strategies that improve health, quality of life and overall well-being. If you have questions or concerns, reach out to your healthcare provider and remember—you don't have to manage this alone.

(References)

  • * Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2024 Mar;30(3):616-621. doi: 10.1038/s41591-023-02791-0. PMID: 38431872.

  • * Apovian CM, Arterburn DE, Bartness TJ, et al. A Narrative Review of the Pathophysiology, Diagnosis, and Treatment of Obesity. JAMA. 2024 Feb 27;331(8):695-707. doi: 10.1001/jama.2024.1084. PMID: 38407481.

  • * Ryan DH, Kahan S, Aronne LJ. Obesity as a Chronic Disease: A New Paradigm for Treatment. Med Clin North Am. 2023 Nov;107(6):1059-1070. doi: 10.1016/j.mcna.2023.05.008. PMID: 37884488.

  • * Schwartz MW, Seeley RJ, Zeltser LM, et al. Is obesity a brain disease? A review of the science. Brain Res. 2024 Mar 22;148816. doi: 10.1016/j.brainres.2024.148816. PMID: 38522612.

  • * Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8. PMID: 30872752.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.